Matches in Wikidata for { <http://www.wikidata.org/entity/Q52592624> ?p ?o ?g. }
- Q52592624 description "2018 nî lūn-bûn" @default.
- Q52592624 description "2018 թվականի ապրիլի 11-ին հրատարակված գիտական հոդված" @default.
- Q52592624 description "2018年の論文" @default.
- Q52592624 description "2018年学术文章" @default.
- Q52592624 description "2018年学术文章" @default.
- Q52592624 description "2018年学术文章" @default.
- Q52592624 description "2018年学术文章" @default.
- Q52592624 description "2018年学术文章" @default.
- Q52592624 description "2018年学术文章" @default.
- Q52592624 description "2018年學術文章" @default.
- Q52592624 description "2018年學術文章" @default.
- Q52592624 description "2018年學術文章" @default.
- Q52592624 description "2018年學術文章" @default.
- Q52592624 description "2018年學術文章" @default.
- Q52592624 description "2018년 논문" @default.
- Q52592624 description "article científic" @default.
- Q52592624 description "article scientific" @default.
- Q52592624 description "article scientifique" @default.
- Q52592624 description "articol științific" @default.
- Q52592624 description "articolo scientifico" @default.
- Q52592624 description "artigo científico" @default.
- Q52592624 description "artigo científico" @default.
- Q52592624 description "artigo científico" @default.
- Q52592624 description "artikel ilmiah" @default.
- Q52592624 description "artikull shkencor" @default.
- Q52592624 description "artikulong pang-agham" @default.
- Q52592624 description "artykuł naukowy" @default.
- Q52592624 description "artículo científico publicado en 2018" @default.
- Q52592624 description "artículu científicu" @default.
- Q52592624 description "bilimsel makale" @default.
- Q52592624 description "bài báo khoa học" @default.
- Q52592624 description "naučni članak" @default.
- Q52592624 description "scienca artikolo" @default.
- Q52592624 description "scientific article published on 11 April 2018" @default.
- Q52592624 description "scientific article published on 11 April 2018" @default.
- Q52592624 description "scientific article published on 11 April 2018" @default.
- Q52592624 description "teaduslik artikkel" @default.
- Q52592624 description "tieteellinen artikkeli" @default.
- Q52592624 description "tudományos cikk" @default.
- Q52592624 description "vedecký článok" @default.
- Q52592624 description "vetenskaplig artikel" @default.
- Q52592624 description "videnskabelig artikel" @default.
- Q52592624 description "vitenskapelig artikkel" @default.
- Q52592624 description "vitskapeleg artikkel" @default.
- Q52592624 description "vědecký článek" @default.
- Q52592624 description "wetenschappelijk artikel" @default.
- Q52592624 description "wissenschaftlicher Artikel" @default.
- Q52592624 description "επιστημονικό άρθρο" @default.
- Q52592624 description "мақолаи илмӣ" @default.
- Q52592624 description "наукова стаття, опублікована у квітні 2018" @default.
- Q52592624 description "научна статия" @default.
- Q52592624 description "научная статья" @default.
- Q52592624 description "научни чланак" @default.
- Q52592624 description "научни чланак" @default.
- Q52592624 description "מאמר מדעי" @default.
- Q52592624 description "مقالة علمية نشرت في 11 أبريل 2018" @default.
- Q52592624 description "১১ এপ্রিল ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q52592624 description "บทความทางวิทยาศาสตร์" @default.
- Q52592624 description "სამეცნიერო სტატია" @default.
- Q52592624 name "Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer." @default.
- Q52592624 name "Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer." @default.
- Q52592624 type Item @default.
- Q52592624 label "Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer." @default.
- Q52592624 label "Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer." @default.
- Q52592624 prefLabel "Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer." @default.
- Q52592624 prefLabel "Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer." @default.
- Q52592624 P1433 Q52592624-31B1F6B3-1DE7-4AE3-BD4C-8933A99C22F4 @default.
- Q52592624 P1476 Q52592624-784D0719-A35B-43DC-8B58-E6C4C4E0931F @default.
- Q52592624 P2093 Q52592624-420BF499-4867-47BC-B591-B82D2B7B4193 @default.
- Q52592624 P2093 Q52592624-42590C5C-F44D-4849-AAA5-E6DE3833A14A @default.
- Q52592624 P2093 Q52592624-93B7333B-48CA-4D82-BAC6-5AA0A3C8520D @default.
- Q52592624 P2093 Q52592624-93C9D4C0-BE1C-4545-882B-BCFB79B902DF @default.
- Q52592624 P2093 Q52592624-94180057-C40B-4B31-B19F-C1D79FB591DE @default.
- Q52592624 P2093 Q52592624-A366CDF7-8B54-496D-BEB1-B10A179D2503 @default.
- Q52592624 P2093 Q52592624-BC7C7A74-42D8-4F55-BA45-7CBBC01C939A @default.
- Q52592624 P2093 Q52592624-F4F87AAC-BD01-4A09-81C3-3D1FFDAD9DCD @default.
- Q52592624 P2093 Q52592624-F66CC6DF-073E-4265-87CE-A3D76E91B5B5 @default.
- Q52592624 P2093 Q52592624-F8E70B2C-2583-48C8-A0B5-41EB2B3886DE @default.
- Q52592624 P2888 Q52592624-84C964CF-B977-46E2-B6BB-AE0B6F82FE6B @default.
- Q52592624 P304 Q52592624-5BE5B8C7-B5C3-48EA-B170-28DE8FF9CEC0 @default.
- Q52592624 P31 Q52592624-E2129124-22EE-4499-8F2C-D099305C2C6A @default.
- Q52592624 P356 Q52592624-D0637262-18D6-4E0A-9A41-3657EBE4DB28 @default.
- Q52592624 P433 Q52592624-DFDA4102-FAF8-4B12-8DA8-C2E791D7167B @default.
- Q52592624 P478 Q52592624-08DA11E6-E617-47B7-9536-2EECC436C1D8 @default.
- Q52592624 P50 Q52592624-98140BAB-315F-49A7-A49B-5DF15D660374 @default.
- Q52592624 P577 Q52592624-6A799BA1-E4CA-4DC1-96D5-E7843DFEF812 @default.
- Q52592624 P698 Q52592624-032A59EB-BD2D-4520-8E1A-665724E2A2D6 @default.
- Q52592624 P921 Q52592624-80598EFD-1020-44D0-A164-6471BAE0E22B @default.
- Q52592624 P356 S00280-018-3573-0 @default.
- Q52592624 P698 29644460 @default.
- Q52592624 P1433 Q326137 @default.
- Q52592624 P1476 "Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer" @default.
- Q52592624 P2093 "Fumiaki Yoshiike" @default.
- Q52592624 P2093 "Kazunari Tateishi" @default.
- Q52592624 P2093 "Kazuya Hirai" @default.
- Q52592624 P2093 "Kei Sonehara" @default.
- Q52592624 P2093 "Manabu Yamamoto" @default.
- Q52592624 P2093 "Takashi Kobayashi" @default.
- Q52592624 P2093 "Takeshi Masubuchi" @default.
- Q52592624 P2093 "Toshirou Fukushima" @default.